SCHEMBL2513449

SCHEMBL2513449

Cc1ccc(S(=O)(=O)N2CCC(N)C(O)c3ccccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.48
KCNN4 O15554 1/20 0.43
KCNA3 P22001 1/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
DRD3 P35462 2/20 0.42
HRH3 Q9Y5N1 1/20 0.42
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 1/20 0.41
GAA P10253 2/20 0.41
MMP2 P08253 1/20 0.40
TERT O14746 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29325480 0.80 HTR6 (0.46) HTR6KCNN4KCNA3CYP3A4CYP2D6
SCHEMBL27762723 0.79 HTR6 (0.46) HTR6KCNN4KCNA3CYP3A4CYP2D6
SCHEMBL14181120 0.78 HTR6 (0.46) HTR6KCNN4KCNA3CYP3A4CYP2D6
SCHEMBL14211934 0.78 HTR6 (0.46) HTR6KCNN4KCNA3CYP3A4CYP2D6
SCHEMBL28241898 0.77 KCNN4 (0.49) HTR6KCNN4KCNA3CYP3A4CYP2D6
SCHEMBL2516744 0.76 ALDH1A1 (0.39) HTR6LMNANPSR1MAPTUSP2
SCHEMBL6604130 0.75 HTR6 (0.43) HTR6KCNN4KCNA3CYP3A4CYP2D6
SCHEMBL6601432 0.75 HTR6 (0.43) HTR6KCNN4KCNA3CYP3A4CYP2D6
SCHEMBL19214097 0.74 HTR6 (0.42) HTR6KCNN4KCNA3CYP3A4CYP2D6
SCHEMBL28735103 0.73 LMNA (0.52) HTR6KCNN4KCNA3LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273754-B2 Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds ARQULE, INC. (US) 2012-09-25 US disclosed
US-8273754-B2 Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds ARQULE, INC. (US) 2012-09-25 US disclosed
US-8273754-B2 Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds ARQULE, INC. (US) 2012-09-25 US disclosed
EP-2379556-A1 SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS ArQule, Inc. (US) 2011-10-26 EP disclosed
WO-2010078430-A1 SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed
WO-2010078430-A1 SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed
US-20100172867-A1 SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 US disclosed
US-20100172867-A1 SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 US disclosed
US-20100172867-A1 SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100172867-A1 SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS DPYD, MKI67, TYMP HTR6 157/4885KCNN4 3839/4885KCNA3 3818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.